Subdural Pharmacotherapy Device
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Formulations and Indications
Phase Of Development
Preclinical
Sponsors and Collaborators
New York University, School of Medicine, EF
Mechanism of Action
Mechanism Description
a drug delivery implant that periodically administers muscimol through the subdural space
Populations Tested In
Drug-resistant focal neocortical epilepsy
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - NTCG 2009
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link